SGLT2 & GLP-1 in Diabetes Application icon

SGLT2 & GLP-1 in Diabetes 1.0.5

57.4 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

SGLT2 & GLP-1 in Diabetes, developed and published by MedLearning2017, has released its latest version, 1.0.5, on 2024-01-05. This app falls under the Medical category on the Google Play Store and has achieved over 10 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

SGLT2 & GLP-1 in Diabetes APK available on this page is compatible with all Android devices that meet the required specifications (Android 4.1+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.mlg.diabetescares

Updated: 1 year ago

Developer Name: MedLearning2017

Category: Medical

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing SGLT2 & GLP-1 in Diabetes on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

SGLT2 & GLP-1 in Diabetes 1.0.5
2024-01-05 / 57.4 MB / Android 4.1+

About this app

This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.

New features

Small bug fix

App Permissions

Allows applications to open network sockets.
Required to be able to access the camera device.